{"id":3083,"date":"2020-11-03T21:50:57","date_gmt":"2020-11-03T21:50:57","guid":{"rendered":"https:\/\/www.cubasupport.ie\/latest\/?p=3083"},"modified":"2020-11-03T21:50:59","modified_gmt":"2020-11-03T21:50:59","slug":"cuba-develops-another-vaccine-against-the-coronavirus-and-it-is-not-injectable","status":"publish","type":"post","link":"https:\/\/www.cubasupport.ie\/latest\/cuba-develops-another-vaccine-against-the-coronavirus-and-it-is-not-injectable\/","title":{"rendered":"Cuba develops another vaccine against the coronavirus and it is not injectable"},"content":{"rendered":"\n
\"\"
Center for Genetic Engineering and Biotechnology (CIGB) of Cuba. Photo: Dunia \u00c1lvarez Palacios \/ Granma.<\/figcaption><\/figure><\/div>\n\n\n\n

The Cuban scientific community is working today on a third vaccine candidate against COVID-19, the first that is not an injectable and would be applied nasal.<\/strong><\/p>\n\n\n\n

Developed by the Center for Genetic Engineering and Biotechnology (CIGB), this project focuses on immunization through the nasal route since the SARS-CoV-2 virus, which causes COVID-19, is respiratory and infects through the mucosa of the nasopharynx.<\/p><\/blockquote>\n\n\n\n

The Director of Biomedical Research of the CIGB, Gerardo Guill\u00e9n<\/strong> , explained to Prensa Latina that immunization through this route favors the development of a local response, the objective of which is to prevent the disease, colonization and transmission of the pathogen.<\/strong><\/p>\n\n\n\n

Likewise, he explained that the new vaccine candidate is based on a protein from the hepatitis B virus, produced through recombinant genetic engineering in bacteria and yeast in the form of particles, whose properties also enhance the immune system.<\/p>\n\n\n\n

This new vaccine against COVID-19 uses, like the two presented by the Finlay Institute of Cuba, the subunit platform, based on specific proteins obtained from biotechnological methods.<\/p><\/blockquote>\n\n\n\n

“The platform by subunit is, perhaps, the one that takes the longest to provide
a vaccine candidate, but it has the advantage of safety, since it does not
work with a virus or with a complex mixture where there may be
toxic compounds or that generate unexpected effects. in the body,
\u201dGuill\u00e9n explained.<\/p>\n\n\n\n

The CIGB delivered this week the documentation to evaluate said vaccine candidate against COVID-19<\/strong> , after its analysis was approved by the Center for State Control of Medicines and Medical Equipment, the island’s regulatory authority.<\/p>\n\n\n\n

Cuba currently has two drugs against COVID-19 in the clinical trial phase (Soberana 01 and Soberana 02) and it is expected that by the end of 2020 the scientific community will register a fourth vaccine candidate against the pandemic.<\/p><\/blockquote>\n\n\n\n

This was confirmed by the president of the Cuban business group BioCubaFarma, Eduardo Mart\u00ednez, who stressed that the strategy outlined to have
Cuban vaccines against COVID-19 “is going well” and before the end of this year, there will be<\/strong>
four candidates in clinical trials.<\/strong><\/p>\n\n\n\n

\u201cIn 2021 our population will be immunized against this virus.\u00a0Cubans can trust their scientists committed to their homeland, ‘he said.<\/p>\n\n\n\n

\n\n\n\n

source: Cubadebate<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

The Cuban scientific community is working today on a third vaccine candidate against COVID-19, the first that is not an injectable and would be applied nasal. […]<\/a><\/p>\n","protected":false},"author":3,"featured_media":3084,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[36,43],"tags":[],"class_list":["post-3083","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-covid-19","category-featured"],"jetpack_publicize_connections":[],"jetpack-related-posts":[{"id":3251,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-has-four-vaccine-candidates-against-covid-19-on-clinical-trials\/","url_meta":{"origin":3083,"position":0},"title":"Cuba has four vaccine candidates against Covid-19 on clinical trials","author":"Editorial Team","date":"November 27, 2020","format":false,"excerpt":"Cuba has registered four vaccine candidates against Covid-19 that are currently on clinical trials, after Mambisa and Abdala, developed by the Genetic Engineering and Biotechnology Center (CIGB), were authorized for this phase of the study.According to information released on social networks, the regulatory entity of Medicines, Equipment and Medical Devices\u2026","rel":"","context":"In "Covid-19"","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-vacine.jpg?fit=748%2C498&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-vacine.jpg?fit=748%2C498&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-vacine.jpg?fit=748%2C498&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-vacine.jpg?fit=748%2C498&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":5550,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-ships-15-million-abdala-vaccines-to-venezuela\/","url_meta":{"origin":3083,"position":1},"title":"Cuba Ships 1,5 Million Abdala Vaccines To Venezuela","author":"Editorial Team","date":"November 24, 2021","format":false,"excerpt":"\"We want to cooperate with the coronavirus immunisation of this brother country's people, who suffer the consequences of the U.S. blockade,\" Cuban scientists stated.\u00a0 On Saturday, Cuba's Center for Genetic Engineering and Biotechnology (CIGB) announced the delivery of 1,5 million Abdala COVID-19 vaccines to Venezuela. \"We want to cooperate with\u2026","rel":"","context":"In "Cuba"","block_context":{"text":"Cuba","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vene_abdala.jpg_1718483346.jpg?fit=600%2C340&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vene_abdala.jpg_1718483346.jpg?fit=600%2C340&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vene_abdala.jpg_1718483346.jpg?fit=600%2C340&ssl=1&resize=525%2C300 1.5x"},"classes":[]},{"id":1353,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-tests-vaccine-to-strengthen-innate-immunity-to-covid-19\/","url_meta":{"origin":3083,"position":2},"title":"Cuba tests vaccine to strengthen innate immunity to Covid-19","author":"Editorial Team","date":"April 11, 2020","format":false,"excerpt":"A vaccine to strengthen innate immunity and prevent the spread of infectious diseases, such as the novel SARS-CoV-2 coronavirus, is in the final phase of clinical trials, the developers stated.The vaccine has proved to be effective in people confirmed with the disease by preventing the spread of Covid-19 to serious\u2026","rel":"","context":"In "Covid-19"","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Cuba-vacuna-covid.jpg?fit=748%2C498&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Cuba-vacuna-covid.jpg?fit=748%2C498&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Cuba-vacuna-covid.jpg?fit=748%2C498&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Cuba-vacuna-covid.jpg?fit=748%2C498&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":1877,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-develops-effective-peptide-against-covid-19\/","url_meta":{"origin":3083,"position":3},"title":"Cuba develops Effective Peptide Against COVID-19","author":"Editorial Team","date":"May 21, 2020","format":false,"excerpt":"Center for Genetic Engineering and Biotechnology (CIGB) laboratories, La Habana, Cuba. | Photo: Twitter\/@bohemiaonline This protein increases its concentration during viral infections and inflammatory processes. Cuba\u2019s Center for Genetic Engineering and Biotechnology (CIGB) developed the CIGB-258, a new protein effective in Covid-19 treatment. \u201cIt is an immunomodulatory peptide, derived from\u2026","rel":"","context":"In "Covid-19"","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/peptide-tab-.jpg?fit=600%2C340&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/peptide-tab-.jpg?fit=600%2C340&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/peptide-tab-.jpg?fit=600%2C340&ssl=1&resize=525%2C300 1.5x"},"classes":[]},{"id":3883,"url":"https:\/\/www.cubasupport.ie\/latest\/cubas-abdala-vaccine-to-begin-phase-iii-of-clinical-trials\/","url_meta":{"origin":3083,"position":4},"title":"Cuba’s Abdala Vaccine to Begin Phase III of Clinical Trials","author":"Editorial Team","date":"March 10, 2021","format":false,"excerpt":"The Center for Genetic Engineering and Biotechnology\u00a0will guarantee\u00a0the doses needed for this clinical trial in which\u00a042,000 people will take\u00a0part. Cuba's President Miguel Diaz-Canel\u00a0on Saturday informed that the Abdala vaccine will start phase III of clinical trials this week in the provinces of Santiago de Cuba and Guantanamo. \"We are one\u2026","rel":"","context":"In "Featured"","block_context":{"text":"Featured","link":"https:\/\/www.cubasupport.ie\/latest\/category\/news\/featured\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/havana-1.jpeg?fit=1200%2C801&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/havana-1.jpeg?fit=1200%2C801&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/havana-1.jpeg?fit=1200%2C801&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/havana-1.jpeg?fit=1200%2C801&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/havana-1.jpeg?fit=1200%2C801&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":4747,"url":"https:\/\/www.cubasupport.ie\/latest\/cubas-soberana-02-covid-19-vaccine-to-reach-95-efficiency\/","url_meta":{"origin":3083,"position":5},"title":"Cuba’s Soberana 02 COVID-19 Vaccine To Reach 95% Efficiency","author":"Editorial Team","date":"June 27, 2021","format":false,"excerpt":"The\u00a0clinical trial's\u00a0preliminary results show a significant increase in the immune responses of patients between the second and third doses. On Thursday, Cuba\u2019s Finlay Vaccine Institute announced that its Soberana 02 COVID-19 vaccine is most likely to reach\u00a0up to\u00a095 percent efficiency in third phase of clinical trials. FVI scientist Maria Toledo\u2026","rel":"","context":"In "Featured"","block_context":{"text":"Featured","link":"https:\/\/www.cubasupport.ie\/latest\/category\/news\/featured\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8872.jpg?fit=708%2C945&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8872.jpg?fit=708%2C945&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8872.jpg?fit=708%2C945&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8872.jpg?fit=708%2C945&ssl=1&resize=700%2C400 2x"},"classes":[]}],"jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p3xdTY-NJ","jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Centro-de-Ingenieria-Genetica-y-Biotecnologia-CIGB-de-Cuba-580x446-1.jpg?fit=580%2C446&ssl=1","_links":{"self":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts\/3083","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/comments?post=3083"}],"version-history":[{"count":0,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts\/3083\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/media\/3084"}],"wp:attachment":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/media?parent=3083"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/categories?post=3083"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/tags?post=3083"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}